文献速递复苏、休克与脓毒症创伤与烧伤

早期持续输注血管加压素增强限制性液体复苏的血流动力学效果并改善肝撕裂出血性休克模型的生存

Early and sustained vasopressin infusion augments the hemodynamic efficacy of restrictive fluid resuscitation and improves survival in a liver laceration model of hemorrhagic shock.
PubMed 文献 · J Trauma Acute Care Surg · 2017-01-01
一句话结论猪肝撕裂出血性休克模型中,早期持续血管加压素(0.04 U/kg/min)联合限制性盐水复苏提高240分钟生存率并稳定血流动力学,不加重出血。

该研究在40头雄性家猪(32-40 kg)肝撕裂出血性休克模型中采用2×2析因设计,随机接受血管加压素(0.04 U/kg/min)或溶媒经骨内途径从第7分钟输注至第240分钟,以及第30分钟静脉输注等渗氯化钠溶液(12 mL/kg)或不补液。Kaplan-Meier曲线显示血管加压素联合盐水组生存8/10,高于血管加压素不补液组4/10、溶媒联合盐水组3/10和溶媒不补液组3/10,但差异未达统计学显著(log-rank检验p=0.095);logistic回归显示血管加压素对生存有统计学显著获益(p=0.042)。血管加压素使平均主动脉压升高10-20 mmHg,不加剧肝撕裂出血速率(33.9±5.1 vs 33.8±4.8 mL/kg),增加全身血管阻力并减少经毛细血管液体外渗,第60分钟时保留的等渗氯化钠溶液量更多(6.5±2.7 vs 2.4±2.0 mL/kg)。

要点

  • 猪肝撕裂出血性休克模型中,血管加压素0.04 U/kg/min经骨内途径从第7分钟输注至第240分钟,使平均主动脉压升高10-20 mmHg。
  • 血管加压素未加剧肝撕裂出血速率,与溶媒组几乎相同(33.9±5.1 vs 33.8±4.8 mL/kg)。
  • 血管加压素联合等渗氯化钠溶液组240分钟生存8/10,高于其他三组(4/10、3/10、3/10),但log-rank检验p=0.095未达统计学显著。
  • logistic回归显示血管加压素对生存有统计学显著获益(p=0.042)。
  • 血管加压素增加全身血管阻力并减少经毛细血管液体外渗,第60分钟保留的等渗氯化钠溶液量更多(6.5±2.7 vs 2.4±2.0 mL/kg)。

适用人群与场景

  • 雄性家猪(32-40 kg)肝撕裂出血性休克模型,用于研究出血性休克复苏策略。

处置流程与药物剂量

  • 血管加压素0.04 U/kg/min经骨内途径从第7分钟持续输注至第240分钟。
  • 第30分钟静脉输注等渗氯化钠溶液12 mL/kg或不补液。

研究设计与关键结果

  • 研究类型:动物实验(猪肝撕裂出血性休克模型),40头雄性家猪,2×2析因设计随机分组。
  • 主要终点:Kaplan-Meier生存曲线显示血管加压素联合等渗氯化钠溶液组8/10,血管加压素不补液组4/10,溶媒联合盐水组3/10,溶媒不补液组3/10,log-rank检验p=0.095未达统计学显著。
  • logistic回归显示血管加压素对生存有统计学显著获益(p=0.042)。
  • 血管加压素使平均主动脉压升高10-20 mmHg,肝撕裂出血速率与溶媒组几乎相同(33.9±5.1 vs 33.8±4.8 mL/kg)。
  • 血管加压素增加全身血管阻力并减少经毛细血管液体外渗,第60分钟保留的等渗氯化钠溶液量6.5±2.7 vs 2.4±2.0 mL/kg。
  • 第120分钟和第180分钟心肌、肝、脾、肾、小肠和骨骼肌血流在血管加压素组相当或更高。

证据类型、等级与局限

  • 证据类型:动物实验(猪模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在猪肝撕裂出血性休克模型中,早期持续血管加压素输注联合限制性液体复苏可稳定血流动力学并改善240分钟生存,不加重出血或损害器官血流。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Current management of hemorrhagic shock favors restrictive fluid resuscitation before control of the bleeding source. We investigated the additional effects of early and sustained vasopressin infusion in a swine model of hemorrhagic shock produced by liver laceration.

METHODS: Forty male domestic pigs (32-40 kg) had a liver laceration inflicted with an X-shaped blade clamp, 32 received a second laceration at minute 7.5, and 24 received two additional lacerations at minute 15. Using a two-by-two factorial design, animals were randomized 1:1 to receive vasopressin infusion (0.04 U/kg per minute) or vehicle intraosseously from minute 7 until minute 240 and 1:1 to receive isotonic sodium chloride solution (12 mL/kg) intravenously at minute 30 or no fluids.

RESULTS: Kaplan-Meier curves showed greater survival after vasopressin with isotonic sodium chloride solution (8/10) compared to vasopressin without isotonic sodium chloride solution (4/10), vehicle with isotonic sodium chloride solution (3/10), or vehicle without isotonic sodium chloride solution (3/10), but the differences were not statistically significant (p = 0.095 by log-rank test). However, logistic regression showed vasopressin to elicit a statistically significant benefit on survival (p = 0.042). Vasopressin augmented mean aortic pressure between 10 and 20 mm Hg without intensifying the rate of bleeding from liver laceration, which was virtually identical to that of vehicle-treated animals (33.9 ± 5.1 and 33.8 ± 4.8 mL/kg). Vasopressin increased systemic vascular resistance and reduced transcapillary fluid extravasation, augmenting the volume of isotonic sodium chloride solution retained (6.5 ± 2.7 vs 2.4 ± 2.0 mL/kg by minute 60). The cardiac output and blood flow to the myocardium, liver, spleen, kidney, small bowel, and skeletal muscle at minute 120 and minute 180 were comparable or higher in the vasopressin group.

CONCLUSIONS: Early and sustained vasopressin infusion provided critical hemodynamic stability during hemorrhagic shock induced by liver laceration and increased the hemodynamic efficacy of restrictive fluid resuscitation without intensifying bleeding or compromising organ blood flow resulting in improved 240-minute survival.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Gazmuri RJ, Whitehouse K, Whittinghill K, et al. Early and sustained vasopressin infusion augments the hemodynamic efficacy of restrictive fluid resuscitation and improves survival in a liver laceration model of hemorrhagic shock. J Trauma Acute Care Surg. 2017. PMID: 27906869. doi:10.1097/TA.0000000000001318

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。